Related by context. Frequent words. (Click for all words.) 71 refractory chronic lymphocytic 69 TTR amyloidosis 69 Canvaxin 69 novel antibody therapeutics 68 colorectal lung 68 pemphigus vulgaris 68 gastrointestinal mucositis 67 investigational mTOR inhibitor 67 R sorafenib tablets 67 ZFP Therapeutics 67 lung pancreatic 67 breast pancreatic 67 oral deforolimus 67 recurrent glioblastoma multiforme 67 ARIAD vision 66 ThermoDox R 66 metastatic colorectal 66 recurrent glioblastoma 66 immuno inflammatory diseases 66 Parkinson disease multiple sclerosis 66 Ixempra 66 rheumatoid arthritis Crohn disease 66 Kuvan R 65 Vandetanib 65 metastatic renal cell 65 interstitial cystitis IC 65 deforolimus 65 motesanib 65 Zenapax 65 idiopathic pulmonary fibrosis IPF 65 opioid induced bowel dysfunction 65 lymphoma leukemia 65 Daclizumab 65 human antibody therapeutics 64 myeloproliferative disorders 64 StromaCel Inc. 64 hepatitis B HBV 64 rheumatoid arthritis psoriatic arthritis 64 pertuzumab 64 Rituxan rituximab 64 opioid induced constipation OIC 64 Onconase 64 Zolinza 64 Activase 64 post herpetic neuralgia PHN 64 hepatitis C HCV 64 inflammatory autoimmune diseases 64 ovarian breast 64 identify protein biomarkers 64 immunologic diseases 64 relapsing multiple sclerosis 64 TLR9 agonists 64 cardio renal 64 immunological diseases 64 forodesine 64 Panzem R 63 rheumatoid arthritis lupus 63 receiving VELCADE 63 thrombotic disorders 63 multiple myeloma MM 63 VEGFR2 inhibitor 63 cirrhosis liver cancer 63 systemic fungal infections 63 Panzem R NCD 63 novel RNAi therapeutics 63 relapsed multiple myeloma 63 Nexavar sorafenib 63 tremelimumab 63 AEG# 63 Nexavar ® 63 elinogrel 63 pancreatic adenocarcinoma 63 RhuDex ® 63 HER2 positive metastatic breast 63 Severe VOD 63 ALN TTR 63 Nanobody 63 TYZEKA 63 rheumatoid arthritis psoriasis 63 predictive biomarkers 63 hepatitis C lupus 63 neurovascular diseases 63 Proxinium TM 63 cognitive impairment associated 63 therapeutic monoclonal antibodies 63 Prestara 62 advanced carcinoid 62 castrate resistant prostate cancer 62 diabetic gastroparesis 62 oral squamous cell 62 neratinib 62 Phase IIb clinical trials 62 interferon gamma 1b 62 gastrointestinal stromal tumors GIST 62 ixabepilone 62 commercializes innovative biopharmaceuticals 62 cediranib 62 phenylketonuria PKU developed 62 PARP inhibitor 62 ® bortezomib 62 MicroDose